首页> 外文期刊>Clinical Biochemistry >A genomic approach to mutation analysis of holocarboxylase synthetase gene in three Chinese patients with late-onset holocarboxylase synthetase deficiency.
【24h】

A genomic approach to mutation analysis of holocarboxylase synthetase gene in three Chinese patients with late-onset holocarboxylase synthetase deficiency.

机译:一种基因组学方法对三例中国迟发性全羧化酶合成酶缺乏症患者的全羧化酶合成酶基因进行突变分析。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: Multiple carboxylase deficiency (MCD, MIM:253270) is a common organic aciduria and caused by deficiency of either biotinidase or holocarboxylase synthetase (HLCS; EC 6.3.4.10). Patients commonly present during early infancy with acute metabolic derangements and severe metabolic acidosis. Recently, a late onset form of HLCS deficiency was also described. The different phenotypes (early and late presenting) may be related to a spectrum of mutations in HLCS gene. Applications of mutation analysis in HLCS had been limited previously by the requirement of cDNA from living tissue for study. We described here a genomic approach for molecular diagnosis of HLCS deficiency which we have used to detect mutations in Chinese patients who had the late-onset form of HLCS deficiency. In addition, a fibroblast cell line with MCD from Coriell Cell repositories was also studied. DESIGN AND METHODS: Three Chinese patients with late onset HLCS deficiency were studied. The genomic sequence of HLCS was retrieved and newly designed primers were used to cover all coding sequences of the gene. PCR products were analyzed by direct sequencing. Population allelic frequencies of mutations detected were determined by genotyping of control samples by restriction fragment length polymorphism. RESULTS: We found a recurrent mutation, R508W, in the three unrelated Chinese patients. Two were homozygous for this mutation. The other patient was a compound heterozygote of R508W and a novel mutation, D634N. The results suggest that R508W may be an important and relatively prevalent disease-causing mutation in Chinese MCD patients. A fibroblast cell-line from an African patient revealed an additional novel mutation, R565X and a known mutation, V550M. CONCLUSION: R508W is a recurrent mutation in Chinese MCD patients which is associated with the late onset phenotype. This new genomic approach for mutation analysis of HLCS gene provides new opportunities in studies of MCD.
机译:目的:多种羧化酶缺乏症(MCD,MIM:253270)是一种常见的有机酸尿症,由生物素酶或全羧化酶合成酶(HLCS; EC 6.3.4.10)缺乏引起。患者通常在婴儿早期出现急性代谢紊乱和严重的代谢性酸中毒。最近,还描述了迟发性HLCS缺乏症。不同的表型(早期出现和晚期出现)可能与HLCS基因中的一系列突变有关。以前,由于需要从活组织中获取cDNA进行研究,因此在HLCS中进行突变分析的应用受到了限制。我们在这里描述了一种基因组学方法,用于分子诊断HLCS缺乏症,我们已经使用该方法来检测患有HLCS缺乏症的中国患者的突变。另外,还研究了具有来自Coriell Cell储存库的MCD的成纤维细胞系。设计和方法:研究了三例中国晚期HLCS缺乏症患者。检索HLCS的基因组序列,并使用新设计的引物覆盖该基因的所有编码序列。通过直接测序分析PCR产物。通过限制片段长度多态性对对照样品进行基因分型来确定检测到的突变的群体等位基因频率。结果:我们在三名无关的中国患者中发现了一个复发性突变R508W。两个是该突变的纯合子。另一例患者是R508W和新突变D634N的复合杂合子。结果表明,R508W可能是中国MCD患者中一个重要且相对普遍的致病突变。来自非洲患者的成纤维细胞系显示出另一个新突变R565X和一个已知突变V550M。结论:R508W是中国MCD患者的复发突变,与晚期发作表型有关。这种用于HLCS基因突变分析的新基因组方法为MCD研究提供了新的机会。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号